Evidence map›Paper›PMID 40710206›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

Prioritizing the Timely Detection and Diagnosis of Early-Age Onset Cancer to Enable Optimal Disease Management and Outcomes.

Michael J Raphael, Petra Wildgoose, Darren Brenner, Christine Brezden-Masley, Ronald Burkes, Robert C Grant, Alexandra Pettit, Cassandra Macaulay, Monika Slovinec D'Angelo, Filomena Servidio-Italiano

Abstract readConference Proceedings
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Unpacking cancer diagnosis among Latin Americans in Canada: disparities and protective patterns.Canadian journal of public health = Revue canadienne de sante publique · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Michael J RaphaelSunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
Petra WildgooseSunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
Darren BrennerDepartments of Oncology and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
Christine Brezden-MasleyMount Sinai Hospital, Toronto, ON M5G 1X5, Canada.ORCID 0000-0002-4818-318X
Ronald BurkesMount Sinai Hospital, Toronto, ON M5G 1X5, Canada.ORCID 0000-0001-5956-3623
Robert C GrantPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada.
Alexandra PettitHorizon Health Network, Fredericton, NB E3B 3B7, Canada.
Cassandra MacaulayColorectal Cancer Resource & Action Network (CCRAN), Toronto, ON M4W 3E2, Canada.
Monika Slovinec D'AngeloSchool of Psychology, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
Filomena Servidio-ItalianoColorectal Cancer Resource & Action Network (CCRAN), Toronto, ON M4W 3E2, Canada.ORCID 0009-0009-1079-2295

Funding

AstraZeneca, Merck, GSK, Takeda, Amgen, Bayer, Coulson Con-tracting, Incyte, Johnson & Johnson and Natera Signatera, as well as Global News. N/A
6 · The paper itself

Abstract

In November 2024, the fourth annual Symposium focusing on early-age onset cancer (EAOC) was hosted by the Colorectal Cancer Resource & Action Network (CCRAN), assembling clinicians, researchers, and patients virtually to discuss challenges in early detection and diagnosis of individuals afflicted with EAOC across tumour types. The meeting addressed the rising rates of EAOC and identified strategies to overcome barriers to timely detection and diagnosis by closing gaps in public and healthcare provider knowledge on symptoms of cancer in younger adults and reducing inequities in standard screening for younger age groups. Discussions also encompassed the various factors that serve as impediments to accessing diagnostic testing and obtaining results, as well as the critical need for access to diagnostics such as comprehensive genomic profiling (CGP), the results of which could be imperative in helping to guide clinical decisions regarding effective and well-tolerated targeted therapies. The Symposium generated key calls to action regarding increasing EAOC education and awareness among primary care providers and the public, re-evaluation of cancer screening programs' eligibility criteria to include younger populations, and mechanisms to reduce waiting times for diagnostic testing by addressing technologist shortages and improving access to CGP through national collaborative strategies and increased funding.

Indexed as

Early Detection of CancerNeoplasmsAge of OnsetDisease ManagementHumanscomprehensive genomic profilingdisease awarenessEAOCearly-age onset cancer

Identifiers

PMID40710206
PMCPMC12293352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.